These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 20707381)
1. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381 [TBL] [Abstract][Full Text] [Related]
2. Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy. Yang HW; Hua MY; Liu HL; Tsai RY; Chuang CK; Chu PC; Wu PY; Chang YH; Chuang HC; Yu KJ; Pang ST ACS Nano; 2012 Feb; 6(2):1795-805. PubMed ID: 22248493 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
4. Magnetic-nanoparticle-modified paclitaxel for targeted therapy for prostate cancer. Hua MY; Yang HW; Chuang CK; Tsai RY; Chen WJ; Chuang KL; Chang YH; Chuang HC; Pang ST Biomaterials; 2010 Oct; 31(28):7355-63. PubMed ID: 20609471 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide- Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625 [TBL] [Abstract][Full Text] [Related]
6. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. Nehilla BJ; Allen PG; Desai TA ACS Nano; 2008 Mar; 2(3):538-44. PubMed ID: 19206580 [TBL] [Abstract][Full Text] [Related]
7. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508 [TBL] [Abstract][Full Text] [Related]
8. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma. Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806 [TBL] [Abstract][Full Text] [Related]
9. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery. Chen ML; He YJ; Chen XW; Wang JH Langmuir; 2012 Nov; 28(47):16469-76. PubMed ID: 23131026 [TBL] [Abstract][Full Text] [Related]
10. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076 [TBL] [Abstract][Full Text] [Related]
11. In vitro targeted imaging and delivery of camptothecin using cetuximab-conjugated multifunctional PLGA-ZnS nanoparticles. Deepagan VG; Sarmento B; Menon D; Nascimento A; Jayasree A; Sreeranganathan M; Koyakutty M; Nair SV; Rangasamy J Nanomedicine (Lond); 2012 Apr; 7(4):507-19. PubMed ID: 22471719 [TBL] [Abstract][Full Text] [Related]
12. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Ling Y; Wei K; Luo Y; Gao X; Zhong S Biomaterials; 2011 Oct; 32(29):7139-50. PubMed ID: 21726899 [TBL] [Abstract][Full Text] [Related]
13. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer. Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872 [TBL] [Abstract][Full Text] [Related]
14. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Mukerjee A; Vishwanatha JK Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921 [TBL] [Abstract][Full Text] [Related]
15. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340 [TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
17. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging. Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087 [TBL] [Abstract][Full Text] [Related]
18. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
20. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]